Concepedia

David A. Bullough

DA

28

Publications

1.4K

Citations

21

H-Index

1982

Active since

Affiliations

University of California San Diego(Current)

Genomatica (United States)

St Thomas' Hospital

Fleet Science Center

David A. Bullough is an author at University of California San Diego specializing in medicine, pharmacology, and physiology.

Top concepts

Publications per year

1982–2017

28

Publications

28

Protective effect of an adenosine kinase inhibitor in septic shock.

Gary S. Firestein, D Boyle, David A. Bullough et al. · The Journal of Immunology · 1994 · 138 citations · Full text

, , +17

Liver-Targeted Drug Delivery Using HepDirect Prodrugs

Mark D. Erion, Paul D. van Poelje, Deidre A. MacKenna et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 117 citations

Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins.

Gary S. Firestein, David A. Bullough, Mark D. Erion et al. · The Journal of Immunology · 1995 · 109 citations

, , +18

Inactivation of the bovine heart mitochondrial F1-ATPase by 5'-p-fluorosulfonylbenzoyl[3H]inosine is accompanied by modification of tyrosine 345 in a single beta subunit.

David A. Bullough, W S Allison · Journal of Biological Chemistry · 1986 · 104 citations · Full text

Three copies of the beta subunit must be modified to achieve complete inactivation of the bovine mitochondrial F1-ATPase by 5'-p-fluorosulfonylbenzoyladenosine.

David A. Bullough, W S Allison · Journal of Biological Chemistry · 1986 · 86 citations · Full text

Rows per page

1–5 of 28